The problem is national, even global, in scope. But it's being felt acutely in Colorado's biosciences community of mostly small companies served by a dwindling handful of local venture-capital firms.
To a degree, it's a symptom of the success the state has had in fostering the 18,000-employee bioscience sector in Colorado, Brown said. High-quality research and innovation are in ample supply; it's the financing that's lagging."
No comments:
Post a Comment